In AD and obesity, brain insulin resistance denotes reduced neuronal and glial responsiveness to insulin, characterized by impaired IRS-1/PI3K-AKT signaling, increased inhibitory serine phosphorylation of IRS-1, and downstream overactivation of GSK3β that favors tau phosphorylation [39]. The gene discussed is AKT1; the disease is Insulin resistance.